PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

✍ Scribed by Mark J McKeage, Michael B Jameson, Ramesh K Ramanathan, Joseph Rajendran, Yongchuan Gu, William R Wilson, Teresa J Melink, N Simon Tchekmedyian

• Book ID: 119897531
• Publisher: BioMed Central
• Year: 2012
• Tongue: English
• Weight: 258 KB
• Volume: 12
• Category: Article
• ISSN: 1471-2407
• DOI: 10.1186/1471-2407-12-496